DB

Teledyne e2v HiRel Releases Best-in-Class, Ultra-Low Noise Amplifier for Space Applications

Retrieved on: 
Tuesday, September 19, 2023

Teledyne e2v HiRel Electronics announces the availability of an industry leading, rad-tolerant, L- and S-band, low noise amplifier, model TDLNA002093SEP that is ideal for use in demanding high-reliability space and radar applications where low noise figure, minimal power consumption, and small package footprint are critical to mission success.

Key Points: 
  • Teledyne e2v HiRel Electronics announces the availability of an industry leading, rad-tolerant, L- and S-band, low noise amplifier, model TDLNA002093SEP that is ideal for use in demanding high-reliability space and radar applications where low noise figure, minimal power consumption, and small package footprint are critical to mission success.
  • “Today we’re releasing our lowest noise figure LNA optimized for space and radar applications,” said Mont Taylor, Vice President and Business Development Manager at Teledyne e2v HiRel.
  • For more information on all of Teledyne e2v HiRel’s space offerings, review our portfolio of semiconductors, converters, processors, and related services here on the Teledyne e2v HiRel website.
  • Devices are available for ordering and shipment today, from Teledyne e2v HiRel or an authorized distributor , in commercial versions and with the option of Classes H and K-equivalent screening.

DataStax Delivers New JSON API: Enabling the World’s Largest Community of Developers to Easily Build Generative AI Applications with the Astra DB Vector Database

Retrieved on: 
Tuesday, September 19, 2023

Available via the open source data API gateway, Stargate , the new JSON API lets JavaScript developers easily leverage Astra DB as a vector database for their large language model (LLM), AI assistant, and real-time generative AI projects.

Key Points: 
  • Available via the open source data API gateway, Stargate , the new JSON API lets JavaScript developers easily leverage Astra DB as a vector database for their large language model (LLM), AI assistant, and real-time generative AI projects.
  • This makes it simple for JavaScript developers – the largest community of developers in the world – to build generative AI applications with vector search, using the library they know and love.
  • The Astra DB vector database is designed for building real-world, production-level AI applications with real-time data.
  • The flexibility of Cassandra lends itself to such enhancements, and this new JSON API for Astra DB is right in line with the emerging needs of DataStax developers.”
    For more information on the JSON API for Astra DB and how to build generative AI applications with DataStax, read the blog here .

Essentium Helps Deutsche Bahn Expand Additive Manufacturing for Faster Train Maintenance

Retrieved on: 
Wednesday, September 20, 2023

AUSTIN, Texas, Sept. 20, 2023 /PRNewswire/ -- Essentium, Inc., a worldwide leader in industrial additive manufacturing (AM), today announced Deutsche Bahn (DB), the national railway company of Germany, has certified the use of Essentium High Speed Extrusion (HSE™) 3D Printing Platform located in Neumunster and high-performance materials for 3D printed train parts and tools. Essentium's 3D printing technology, including flame-retardant Essentium 9085 and HTN-CF25 thermoplastics, has been tested to demonstrate that it complies with the AM Standard ISO/ASTM 52920:2023 and ISO 52920. Essentium's AM solutions will allow DB to increase the availability of its fleet through fast and efficient replacement of parts and tools.

Key Points: 
  • By leveraging Essentium's AM technology, DB aims to overcome supply chain issues and raw materials shortages for obsolete parts.
  • The Essentium HSE 3D Printing Platform in Neumunster and materials will help Deutsche Bahn enhance delivery speed and lower costs by creating low-run parts on demand rather than mass manufacturing and storing vast quantities.
  • Said Blake Teipel, Ph.D., CEO of Essentium: "A lot of people still wonder if additive is ready for prime time.
  • Deutsche Bahn, which is 3D printing tens of thousands of replacement parts for its trains, proves it is.

HashCash Offers Its White-Label Crypto Exchange Services to India-Based Global Enterprise

Retrieved on: 
Saturday, September 16, 2023

PALO ALTO, Calif., Sept. 16, 2023 /PRNewswire-PRWeb/ -- The US-based global blockchain development company, HashCash Consultants has received several awards for its top-notch white label crypto exchange software underpinned by state-of-the-art blockchain technology. The advanced software solution is utilized by several leading financial institutions around the world. Collaborating with financial enterprises worldwide, HashCash consultants are bringing new strategies and contributing to the growing crypto industry. Recently, the company joined hands with an India-based global enterprise to provide its white-label crypto exchange solution.

Key Points: 
  • The global blockchain development company, HashCash Consultants offers its white-label crypto exchange solution to an India-based global enterprise.
  • Recently, the company joined hands with an India-based global enterprise to provide its white-label crypto exchange solution.
  • India is an evolving country, and with the recent growth in crypto adoption, it is a step ahead in becoming the next global crypto hub.
  • The collaboration between HashCash Consultants and the India-based global enterprise is a significant step towards the growth and adoption of cryptocurrencies in India.

Alnylam Reports Positive Topline Results from KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran, an Investigational RNAi Therapeutic in Development to Treat Hypertension in Patients at High Cardiovascular Risk

Retrieved on: 
Thursday, September 7, 2023

The study results indicate zilebesiran was associated with dose-dependent, potent and durable knockdown of serum AGT levels through Month 6.

Key Points: 
  • The study results indicate zilebesiran was associated with dose-dependent, potent and durable knockdown of serum AGT levels through Month 6.
  • Zilebesiran also demonstrated an encouraging safety and tolerability profile that the company believes supports continued development.
  • These findings of robust and tonic blood pressure control will help determine the optimal dose and regimen of zilebesiran for future studies.
  • “Hypertension is a growing global health crisis responsible for around 10 million deaths worldwide each year.

BPAS Earns Top Spots in 2023 NAPA Advisors' Choice Awards

Retrieved on: 
Monday, September 11, 2023

BPAS also received top honors in the 2022 NAPA Advisor Choice Awards.

Key Points: 
  • BPAS also received top honors in the 2022 NAPA Advisor Choice Awards.
  • "We couldn't be more excited by and grateful for these results," said Paul Neveu, BPAS CEO.
  • That approach seems to be resonating today, as so many firms have been disrupted by turnover following acquisitions.
  • In fact, BPAS clients save 45% more time with BPAS than with previous administrators using recordkeeping.

HashCash to Provide White Label Crypto Exchange Software to a UAE-Based Enterprise

Retrieved on: 
Friday, September 8, 2023

PALO ALTO, Calif., Sept. 8, 2023 /PRNewswire-PRWeb/ -- The global blockchain development company, HashCash Consultants has received several accolades for its cutting-edge white label crypto exchange software used by leading financial institutions worldwide. It has been collaborating with financial enterprises worldwide with new strategies, thus fueling crypto development and adoption. Lately, the company has extended its white-label services to a UAE-based major enterprise.

Key Points: 
  • HashCash Consultants, a global blockchain development company provides its white-label crypto exchange software to a UAE-based major enterprise.
  • PALO ALTO, Calif., Sept. 8, 2023 /PRNewswire-PRWeb/ -- The global blockchain development company, HashCash Consultants has received several accolades for its cutting-edge white label crypto exchange software used by leading financial institutions worldwide.
  • We are excited to extend our cutting-edge technology and strategic approach that will enable enterprises to kickstart their crypto exchange platform.
  • The crypto community is thriving across the UAE with a high number of crypto exchanges and users.

Buoyant Announces Linkerd 2.14 with Improved Enterprise Multi-cluster, Gateway API Conformance, and more

Retrieved on: 
Wednesday, August 23, 2023

SAN FRANCISCO, Aug. 23, 2023 /PRNewswire-PRWeb/ -- Buoyant, creator of Linkerd, today announced the release of Linkerd 2.14 with improved support for multi-cluster deployments on shared flat networks, full Gateway API conformance, and much more. Linkerd 2.14 comes on the heels of the Linkerd 2.13 release with circuit breaking and dynamic request routing, and continues Linkerd's focus on coupling enterprise-grade power and flexibility with superior operational model simplicity and to create the lowest TCO of any service mesh.

Key Points: 
  • Buoyant, creator of Linkerd, today announced the release of Linkerd 2.14 with improved support for multi-cluster deployments on shared flat networks, full Gateway API conformance, and much more.
  • SAN FRANCISCO, Aug. 23, 2023 /PRNewswire-PRWeb/ -- Buoyant , creator of Linkerd, today announced the release of Linkerd 2.14 with improved support for multi-cluster deployments on shared flat networks, full Gateway API conformance, and much more.
  • "Linkerd's conformance to the mesh profile of the Gateway API is a big step forward for the project," said Rob Scott, Gateway API maintainer and Staff Software Engineer at Google.
  • "We're thrilled to see Linkerd further cement the Gateway API as the standard mechanism for configuring not just ingress but service mesh functionality on Kubernetes."

Employers eyeing enhancements to nonqualified retirement plans, WTW survey finds

Retrieved on: 
Wednesday, August 16, 2023

The vast majority of large U.S. employers currently offer nonqualified retirement plans to executives and high-income earners.

Key Points: 
  • The vast majority of large U.S. employers currently offer nonqualified retirement plans to executives and high-income earners.
  • Nonqualified plans are typically not subject to rules governed by the Employee Retirement Income Security Act.
  • The WTW Nonqualified Retirement Benefit Survey found over half of respondents (55%) either made changes to their nonqualified defined benefit (DB) retirement plans in the past two years or plan to make changes in the next two years.
  • Other key findings from the survey include:
    Sponsorship: More than half of respondents (56%) offer only a nonqualified DC retirement plan, while 35% sponsor both a nonqualified DC and DB plan.

Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements

Retrieved on: 
Thursday, August 10, 2023

IRVINE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced financial results for the second quarter ended June 30, 2023, and recent business achievements.

Key Points: 
  • Completed enrollment of Galatea, a Phase 2a trial evaluating TP-04 for Rosacea, with topline data expected in 1H 2024
    IRVINE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced financial results for the second quarter ended June 30, 2023, and recent business achievements.
  • “The FDA approval of XDEMVY for the treatment of Demodex blepharitis is a seminal milestone for Tarsus, the eye care community and most importantly for patients, many of whom have struggled for years without an approved, effective treatment option,” said Bobak Azamian, MD, PhD, Chief Executive Officer and Chairman of Tarsus.
  • “We are well-positioned and well-funded, expect to launch XDEMVY later this month to capture the potentially very significant patient demand, and anticipate rapid adoption among eye care providers and meaningful prescription volume in the early days following XDEMVY’s entrance into the market.”
    First and only approved therapeutic for DB, a highly prevalent eyelid disease that impacts approximately 25 million eye care patients in the U.S.
    XDEMVY targets the root cause of DB and in pivotal trials demonstrated significant improvement in eyelids (reduction of collarettes, the pathognomonic sign of the disease, to no more than 2 collarettes per upper lid), mite eradication (mite density of 0 mites per lash) and erythema cure (Grade 0)
    Completed recruitment of our 85-person sales force targeting ~15K optometrists and ophthalmologists, which represents >80% of the projected market; expect sales force to be deployed by the end of August when we anticipate product to be available
    “Look at the Lids” disease education campaign has generated nearly 300K unique website visits, up from 200K last quarter and nearly 3M digital/media impressions, an increase of 700K impressions since last quarter